Quarterly report pursuant to Section 13 or 15(d)

Debt

 v2.3.0.11
Debt
6 Months Ended
Jun. 30, 2011
Debt [Abstract]  
Debt
(3) Debt

We have a loan agreement with a group of banks that was entered into in June 2011 to make the WBI acquisition and provide working capital for our continuing operations. The loan agreement consists of a term loan facility and a revolving loan facility, and the revolving loan facility provides us with letters of credit. The loan agreement, which expires in June 2016, replaced a loan agreement that also consisted of a term loan, revolving loan, and letters of credit.
 
The term loan requires payments in quarterly installments based on an accelerating amortization schedule, with fifteen percent of the original $125 million principal amount due in each of the first two years, twenty percent due in each of years three and four, and thirty percent due in year five. The amount of term loan borrowings outstanding as of June 30, 2011 is approximately $120.3 million. The amount of term loan borrowings outstanding on the predecessor loan agreement as of December 31, 2010 was approximately $17.8 million.
 
Our scheduled term loan payments are: $9.4 million before 2012, $18.8 million in 2012, $23.4 million in 2013, $25 million in 2014, $34.3 million in 2015, and $9.4 million in 2016.
 
The maximum amount of credit available to us for revolving loans and letters of credit as of June 30, 2011 was $125 million and the loan agreement has a provision whereby we may elect to increase this maximum to a total of $175 million. We may borrow revolving loan amounts at any time and can repay the borrowings at any time without premium or penalty. We pay fees on letters of credit that are issued. We had approximately $71.9 million in revolving loan borrowings outstanding and $5 million of letters of credit outstanding as of June 30, 2011. We had approximately $6.9 million of letters of credit outstanding and no revolving loan borrowings outstanding as of December 31, 2010 on the predecessor loan agreement.
 
Total borrowed funds outstanding as of June 30, 2011, including both term loan borrowings and revolving loan borrowings, were approximately $192.2 million. Total borrowed funds outstanding as of December 31, 2010, were approximately $17.8 million.
 
We incurred financing costs of approximately $1.7 million in connection with this loan agreement.  These costs were capitalized and will be amortized over the life of the loan, which is five years.
 
We pay interest on the term loan borrowings and revolving loan borrowings at LIBOR plus a base margin or at a base rate (typically the prime rate) plus a base margin. The LIBOR base margin as of June 30, 2011 is 2.25% and the base rate base margin as of June 30, 2011 is 0.5%. The base margins decline in steps as our Total Funded Debt/Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”) ratio declines. As of June 30, 2011, interest rates on portions of our outstanding debt ranged from 2.44% to 3.75%. The effective interest rate on our aggregate outstanding debt as of June 30, 2011 was 2.51%.
 
Interest expense incurred on bank loan borrowings for the three months ended June 30, 2011 was approximately $448 thousand and approximately $35 thousand for the same period of the prior year. Interest expense incurred on bank loan borrowings for the six months ended June 30, 2011 was approximately $614 thousand and approximately $67 thousand for the same period of the prior year.
 
The loan agreement contains collateral requirements that secure our assets, restrictive covenants, other affirmative and negative covenants, and subjects us to certain conditions and limitations. Restrictive covenants include a maximum Total Funded Debt/EBITDA ratio, which decreases over time, and a minimum Fixed Charge Coverage Ratio. We were in compliance with required ratios and other terms and conditions at June 30, 2011.